Indy-based Vertellus acquires chemical maker in U.K.
The addition of Pentagon Chemicals UK Ltd. could add at least $75 million in revenue to the top line of Vertellus Speciaties Inc., one of the largest private firms in Indianapolis.
Life Science & Biotech
Articles
Research firm Covance to be acquired in $6.1 billion deal
Covance manages clinical trials for drugmakers including locally-based Eli Lilly and Co. It employs about 1,500 workers in Indianapolis and Greenfield.
Why small Hoosier employers aren’t dropping their health plans—yet
Obamacare's community rating rules would give 25-percent-off coupons to boomers while sticking millennials with a 75-percent surcharge, according to recent data from employer health plans.
Zimmer to become Zimmer Biomet after acquisition
Orthopedic device maker Zimmer said Thursday it will be called Zimmer Biomet after its combination with privately held competitor Biomet.
BioCrossroads: Life sciences funding hit $25B in past decade
In the decade after the founding of the BioCrossroads initiative, money spent on life sciences research and companies more than doubled, according to a report released Thursday by the Indianapolis-based life sciences business development group.
Hoosier medical device companies look off shore
Slowing domestic growth pushes executives to brighter markets.
Eli Lilly donates $12.7 million to United Way
The donation represents the giving of employees and retirees of Lilly and Elanco Animal Health in the U.S. and Puerto Rico, plus a matching contribution from the Lilly Foundation.
Lechleiter: It’s morning at Eli Lilly
Lilly CEO John Lechleiter kicked off the company’s quarterly conference call with investors and analysts by declaring an end to the “unprecedented challenge” that Lilly lived through the past four years.
The tragedy of electronic medical records
The federal government has spent $27 billion—and hospital systems have spent even more—to roll out electronic medical records across the industry. But even advocates say the results have been “disappointing.”
Dow Agro reports flat quarterly sales, smaller profit
Dow AgroSciences reported stagnant sales in the third quarter Wednesday morning on softer sales of crop-protection products. Meanwhile, parent company Dow Chemical beat expectations with its quarterly report.
Report provides glimpse into liberal concerns about Pence’s HIP 2.0
A new think tank report, which appears to jibe with Obama administration concerns, calls for “significant revision” to the Pence plan.
Dow Agro’s Enlist weed killer cleared by EPA
Enlist Duo can be used in six states, with approval pending in another 10, the Environmental Protection Agency said Wednesday. Dow is counting on the system to help double earnings at Dow AgroSciences in five to seven years.
While Pence and Obama dance, these folks are waiting
The Hoosiers waiting for Gov. Mike Pence and President Obama to work out a deal to expand health coverage have median household incomes of less than $10,000, typically have no college education and are disproportionately minorities.
More hospitals hit with do-over penalties
Medicare will reduce payments to 68 Indiana hospitals—a 62-percent increase from last year—for having too many patients return within 30 days.
If past is prologue, HMOs will make a comeback in Indiana
WellPoint created an HMO joint venture with seven big hospitals in Los Angeles. Could it do something similar here? Quite possibly.
The pain (and pleasure) that comes from paying more of our health care bills
Paying off medical debts over time is now a common experience for families with health insurance and becoming more so. And that is inducing big changes in the health care marketplace.
Why small firms have been irate about health insurance
For Indiana employers with fewer than 10 workers, health insurance premiums have risen 11.5 percent, on average, from 2001 to 2013. That ranked second-highest among all states.
What if hospitals ‘upcharged’ you for being fat?
As local hospitals try to offer package deals with upfront prices on joint replacement surgeries, they're struggling with the reality that patients' other health conditions can significantly increase their cost of care.
USDA approves new modified corn, soybean seeds
The farmers won't be able to take full advantage of the seeds until the EPA issues a second ruling allowing the use of weed killer Enlist. The EPA has said it will rule this fall on Indianapolis-based Dow AgroSciences' application to market the chemical.